Prolonged-release oxycodone/naloxone in postoperative pain management: From a randomized clinical trial to usual clinical practice

Journal of International Medical Research

Volumn 40, Issue 5, 2012, Pages 1775-1793

  Kuusniemi, K ^a   Zollner J ^b   Sjovall S ^c   Huhtala, J ^d   Karjalainen, P ^e   Kokki, M ^f,g   Lemken, J ^b   Oppermann, J ^b   Kokki, Hannu ^f,g  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b SRH Hospital Karlsbad Langensteinbach   (Germany)

^c Central Hospital of Pori   (Finland)

^d Coxa Hospital for Joint Replacement ^*  (Finland)

^e Hospital of Oulaskangas   (Finland)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Analgesics; Bowel function; Knee arthroplasty; Naloxone; Oxycodone; Postoperative pain; Spine surgery; Urinary retention

Indexed keywords

MELOXICAM; NALOXONE PLUS OXYCODONE; OPIATE; PARACETAMOL; NALOXONE; NARCOTIC ANALGESIC AGENT; OXYCODONE;

ADULT; AGED; ARTICLE; BLOATING; BRIEF PAIN INVENTORY; CLINICAL PRACTICE; CONSTIPATION; CONTROLLED STUDY; DEFECATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; FLATULENCE; HUMAN; INTESTINE FUNCTION; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; MICTURITION; MOOD; MULTICENTER STUDY; PAIN INTENSITY; PATIENT ASSESSMENT; PHASE 4 CLINICAL TRIAL; PHYSIOTHERAPY; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PROGRAM EVALUATION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; SLEEP; SURGICAL PATIENT; SUSTAINED DRUG RELEASE; TOTAL QUALITY MANAGEMENT; WALKING; ANALGESIA; CHEMICALLY INDUCED DISORDER; CONTROLLED CLINICAL TRIAL; DELAYED RELEASE FORMULATION; DRUG COMBINATION; MIDDLE AGED; SPINE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ARTHROPLASTY, REPLACEMENT, KNEE; CONSTIPATION; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NALOXONE; OXYCODONE; PAIN MANAGEMENT; PAIN, POSTOPERATIVE; SPINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877735360     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006051204000516     Document Type: Article

References (29)

1. Shipton EA: The transition from acute to chronic post surgical pain. Anaesth Intensive Care 2011; 39: 824-836.
2. Katz J, Seltzer Z: Transition from acute to chronic postsurgical pain: risk factors and protective factors. Expert Rev Neurother 2009; 9: 723-744.
3. Parvizi J, Miller AG, Gandhi K: Multimodal pain management after total joint arthroplasty. J Bone Joint Surg Am 2011; 93: 1075-1084.
4. Shah S, Mehta V: Controversies and advances in non-steroidal anti-inflammatory drug (NSAID) analgesia in chronic pain management. Postgrad Med J 2012; 88: 73-78.
5. Duellman TJ, Gaffigan C, Milbrandt JC, et al: Multi-modal, pre-emptive analgesia decreases the length of hospital stay following total joint arthroplasty. Orthopedics 2009; 32: 167.
6. Kokki H, Kokki M, Sjövall S: Oxycodone for the treatment of postoperative pain. Expert Opin Pharmacother 2012; 13: 1045-1058.
7. Roth SH, Fleischmann RM, Burch FX, et al: Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med 2000; 160: 853-860.
8. Pan H, Zhang Z, Zhang Y, et al: Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain. Clin Drug Investig 2007; 27: 259-267.
9. Sunshine A, Olson NZ, Colon A, et al: Analgesic efficacy of controlled-release oxycodone in postoperative pain. J Clin Pharmacol 1996; 36: 595-603.
10. Cheville A, Chen A, Oster G, et al: A randomized trial of controlled-release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty. J Bone Joint Surg Am 2001; 83: 572-576.
11. Meissner W, Schmidt U, Hartmann M, et al: Oral naloxone reverses opioid-associated constipation. Pain 2000; 84: 105-109.
12. Vondrackova D, Leyendecker P, Meissner W, et al: Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008; 9: 1144-1154.
13. Simpson K, Leyendecker P, Hopp M, et al: Fixedratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-tosevere noncancer pain. Curr Med Res Opin 2008; 24: 3503-3512.
14. Löwenstein O, Leyendecker P, Hopp M, et al: Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe nonmalignant chronic pain: a randomised controlled trial. Expert Opin Pharmacother 2009; 10: 531-543.
15. Smith K, Hopp M, Mundin G: Low absolute bioavailability of oral naloxone in healthy subjects. Int J Clin Pharmacol Ther 2012; 50: 360-367.
16. Jones RD, Jones JG: Intrathecal morphine: naloxone reverses respiratory depression but not analgesia. Br Med J 1980; 281: 645-646.
17. Gan TJ, Ginsberg B, Glass PS, et al: Opioidsparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 1997; 87: 1075-1081.
18. Mikus G: Combining opioid agonists and antagonists as a solution for opioid-induced constipation. Eur Gastroenterol Hepatol Rev 2008; 4: 55-58.
19. Mueller-Lissner S: Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation. Adv Ther 2010; 27: 581-590.
20. Mendoza T, Mayne T, Rublee D, et al: Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain 2006; 10: 353-361.
21. Rentz AM, Yu R, Müller-Lissner S, et al: Validation of the Bowel Function Index to detect clinically meaningful changes in opioidinduced constipation. J Med Econ 2009; 12: 371-383.
22. Ranawat CS, Shine JJ: Duo-condylar total knee arthroplasty. Clin Orthop Relat Res 1973; 94: 185-195.
23. Oretorp N, Gillquist J, Liljedahl SO: Long term results of surgery for non-acute anteromedial rotatory instability of the knee. Acta Orthop Scand 1979; 50: 329-336.
24. Lysholm J, Gillquist J: Evaluation of knee ligament surgery results with special emphasis on use of a scoring scale. Am J Sports Med 1982; 10: 150-154.
25. Hays RD, Sherbourne CD, Mazel RM: The RAND 36-Item Health Survey 1.0. Health Econ 1993; 2: 217-227.
26. Sandner-Kiesling A, Leyendecker P, Hopp M, et al: Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain. Int J Clin Pract 2010; 64: 763-774.
27. Ahmedzai SH, Nauck F, Bar-Sela G: A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliat Med 2012; 26: 50-60.
28. Flory DA, Fankhauser RA, McShane MA: Postoperative pain control in total joint arthroplasty: a prospective, randomized study of a fixed-dose, around-the-clock, oral regimen. Orthopedics 2001; 24: 243-246.
29. de Beer Jde V, Winemaker MJ, Donnelly GA, et al: Efficacy and safety of controlled-release oxycodone and standard therapies for postoperative pain after knee or hip replacement. Can J Surg 2005; 48: 277-283.